According to Pacific Biosciences 's latest financial reports the company's total liabilities are $1.04 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $1.04 B | -13.24% |
2022-12-31 | $1.20 B | -0.97% |
2021-12-31 | $1.21 B | 1449.24% |
2020-12-31 | $78.48 M | -15.66% |
2019-12-31 | $93.06 M | 65.56% |
2018-12-31 | $56.21 M | -3.05% |
2017-12-31 | $57.98 M | 8.95% |
2016-12-31 | $53.21 M | -7.56% |
2015-12-31 | $57.56 M | -17.1% |
2014-12-31 | $69.44 M | 3.64% |
2013-12-31 | $67 M | 230.06% |
2012-12-31 | $20.3 M | -24.4% |
2011-12-31 | $26.85 M | 3.76% |
2010-12-31 | $25.88 M | -90.7% |
2009-12-31 | $0.27 B | 34.73% |
2008-12-31 | $0.20 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $51.88 B | 4,866.35% | ๐บ๐ธ USA |
General Electric GE | $134.46 B | 12,771.04% | ๐บ๐ธ USA |
Illumina ILMN | $4.36 B | 317.92% | ๐บ๐ธ USA |
PerkinElmer
PKI | $6.60 B | 532.17% | ๐บ๐ธ USA |
NanoString Technologies NSTG | $0.32 B | -68.86% | ๐บ๐ธ USA |